For Immediate Release
Chicago, IL – January 18, 2021 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Apple Inc. (
AAPL Quick Quote AAPL - Free Report) , Mastercard Incorporated ( MA Quick Quote MA - Free Report) , Sanofi ( SNY Quick Quote SNY - Free Report) , Comcast Corporation ( CMCSA Quick Quote CMCSA - Free Report) and Altria Group, Inc. ( MO Quick Quote MO - Free Report) . Here are highlights from Friday’s Analyst Blog: Top Stock Reports for Apple, Mastercard and Sanofi
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Apple, Mastercard and Sanofi. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
You can see
all of today's research reports here >>> Apple shares have outperformed the S&P 500 over the past year (+63.5% vs. +16.2%). The Zacks analyst believes that the company is benefiting from continued momentum in the Services segment, driven by a robust performance of App Store, Apple Music, video and cloud services.
Moreover, demand remains healthy for other Apple devices including iPad, Mac and Wearables. Although Apple didn't provide any guidance due to uncertainties triggered by the coronavirus pandemic, it expects iPhone sales to grow in the first quarter of fiscal 2021.
Apple's near-term prospects are bright, driven by new iPhones that support 5G, revamped iPad and Mac line-up of devices, health-focused Apple Watch 6 and robust growth in the Services business. Moreover, a solid balance sheet and strong cash flow generating ability are key catalysts. However, increasing scrutiny and legal woes over App Store are headwinds.
) read the full research report on Apple here >>>
Mastercard have gained +9.2% in the last six months against the Zacks Financial Transaction Services industry's gain of +5.1%. The Zacks analyst believes that the company is gaining from solid demand for digital and contactless solutions amid the COVID crisis.
Investment in technology keeps it at the forefront of the rapidly-evolving payments industry. It is well poised to gain from consistent cash generating abilities from operations backed by its growing business volumes. The company's strong capital position drives investment in business and shareholder value addition.
However, steep costs might stress margins. Its cross-border volumes will remain suppressed due to COVID-19 restriction on travel and entertainment. Its third-quarter earnings missed estimates.
) read the full research report on Mastercard here >>> Sanofi shares have lost -2.5% over the past three months against the Zacks Large Cap Pharmaceuticals industry's rise of +7.2%. The Zacks analyst believes that Sanofi's Specialty Care unit is on a strong footing, particularly with regular label expansion of Dupixent.
The drug has, in a very short time, become the key top-line driver for Sanofi. Sanofi possesses a leading vaccine operation. Its R&D pipeline is strong and several data read-outs are expected in 2021. However, headwinds include weak performance of the Diabetes unit, generic competition for many drugs and slower-than-expected uptake of core products like Praluent.
Meanwhile, COVID-19 has resulted in slowdown of new patient starts, deferral of some vaccinations, and lower in-pharmacy traffic. Shares have underperformed the industry in the past one year. Estimate movement has been mixed ahead of Q4 earnings. Sanofi has a mixed record of earnings surprise in the recent quarters.
) read the full research report on Sanofi here >>>
Other noteworthy reports we are featuring today include Comcast and Altria Group.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
You know this company from its past glory days, but few would expect that it's poised for a monster turnaround. Fresh from a successful repositioning and flush with A-list celeb endorsements, it could rival or surpass other recent Zacks' Stocks Set to Double like Boston Beer Company which shot up +143.0% in a little more than 9 months and Nvidia which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Zacks Investment Research
800-767-3771 ext. 9339
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss
. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.